SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000875045-19-000036
Filing Date
2019-10-01
Accepted
2019-10-01 08:03:01
Documents
16
Period of Report
2019-09-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K october120198-k.htm   iXBRL 8-K 40479
2 EXHIBIT 99.1 pressreleaseoctober12019.htm EX-99.1 19456
8 biogenlogostandardrgbr.jpg GRAPHIC 95992
  Complete submission text file 0000875045-19-000036.txt   452320

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20190929.xsd EX-101.SCH 4588
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT biib-20190929_cal.xml EX-101.CAL 624
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biib-20190929_def.xml EX-101.DEF 1474
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20190929_lab.xml EX-101.LAB 26142
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20190929_pre.xml EX-101.PRE 13580
10 EXTRACTED XBRL INSTANCE DOCUMENT october120198-k_htm.xml XML 4189
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19311 | Film No.: 191127580
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences